CB-182804

CB-182804, Polymyxin B (HY-149179) analogue, is a polypeptide antibiotic. CB-182804 has inhibitory activity against all Gram-negative pathogenic bacteria, including Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa with MIC50 values of 2 μg/mL. CB-182804 is mainly used for the research on refractory infections caused by multidrug-resistant (MDR) Gram-negative bacteria[1].

Product Specifications

CAS Number

[1231767-35-3]

UNSPSC

12352005

Target

Antibiotic; Bacterial; Drug Derivative

Related Pathways

Anti-infection; Others

Field of Research

Infection

Smiles

O=C(N[C@H](C(N[C@@](C(N[C@H](C(N[C@]([C@H](O)C)([H])C(NCC[C@@](NC([C@H](CCN)NC([C@@]([C@H](O)C)([H])NC([C@H](CCN)NC(NC1=C(C=CC=C1)Cl)=O)=O)=O)=O)([H])C(N[C@@H](CCN)C2=O)=O)=O)=O)CCN)=O)([H])CCN)=O)CC(C)C)[C@H](N2)CC3=CC=CC=C3

Molecular Formula

C54H86ClN17O13

Molecular Weight

1216.82

References & Citations

[1]Quale J, et al. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City. Microb Drug Resist. 2012 Apr;18 (2) :132-6.